| |
|
|
[January 12, 2001] |
 |
2001 Childhood Immunization Schedule Now Available
Every year, the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) reviews the recommended childhood immunization schedule. ACIP, the American Academy of Pediatrics, and the American Academy of Family Physicians have added pneumococcal conjugate vaccine to the schedule, and they have extended the recommendation for the hepatitis A vaccine. Last February, the Food and Drug Administration licensed Wyeth Lederle Vaccines and Pediatrics' Prevnar, a heptavalent pneumococcal polysaccharide-protein conjugate vaccine (PCV), for use among infants and small children. Children between two months and 23 months should get four intramuscular doses, and ACIP recommends the vaccine for those between the ages of 24 months and 59 months who are at increased risk for pneumococcal disease. ACIP also recommends that PCV be considered for all other children in that age group, with priority given to those between 24 and 35 months; African-American, Native American, or Alaska Native children; and children who attend child-care centers. ACIP continues its recommendation of hepatitis A vaccine for routine use in some areas, and for 2001, the recommendation has been extended to adolescents through age 18 and those in certain high-risk groups.View the�2001 Childhood Immunization Schedule . From the CDC's Morbidity and Mortality Weekly Report (MMWR), January 12, 2001, Vol. 50, No. 1, p.7
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5001a3.htm
|
|
|
